Martin Shkreli Responds To Australian Students Who Created $2 Version Of Daraprim Pill That ‘Pharma Bro’ Had Jacked Up Price By 5000 Percent
Turing Pharmaceuticals CEO Martin Shkreli appeared upset after he heard a generic variant of Daraprim was successfully synthesized by a few Australian students in their school laboratory. The man, who has earned the infamous nickname “Pharma Bro,” took to social media to chastise and criticize the efforts of the Sydney schoolboys for offering their generic alternative for roughly $2 per dose, as compared to $750 a tablet that Daraprim was being sold for until recently.
Australian high school kids recreate Martin Shkreli price-hike drug Daraprim for $2 a pill in school lab https://t.co/bQwYCNx6ng pic.twitter.com/QCNuCPC1Kr
— Occupy Wall Street (@OccupyWallStNYC) December 1, 2016
“Pharma Bro” Martin Shkreli, who gained notoriety for hiking life-saving medicine Daraprim’s price by 5000 Percent, and endorsed the same pricing strategy adopted by the makers of EpiPen, responded to students who managed to synthesize a generic variant very cheaply in a school laboratory.
@Scottyt2Hottie yea uh anyone can make any drug it is pretty ez
— Martin Shkreli (@MartinShkreli) December 1, 2016
Labor and equipment…